BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30017732)

  • 1. Utilization of hypofractionated radiation therapy in older glioblastoma patients.
    Nead KT; Swisher-McClure S
    J Geriatr Oncol; 2019 Jan; 10(1):155-158. PubMed ID: 30017732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization of hypofractionated radiotherapy in treatment of glioblastoma multiforme in elderly patients not receiving adjuvant chemoradiotherapy: A National Cancer Database Analysis.
    Bingham B; Patel CG; Shinohara ET; Attia A
    J Neurooncol; 2018 Jan; 136(2):385-394. PubMed ID: 29209874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of Care and Outcomes of Hypofractionated Chemoradiation Versus Conventionally Fractionated Chemoradiation for Glioblastoma in the Elderly Population.
    Haque W; Verma V; Butler EB; Teh BS
    Am J Clin Oncol; 2018 Feb; 41(2):167-172. PubMed ID: 29369825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypofractionated versus standard radiation therapy with or without temozolomide for older glioblastoma patients.
    Arvold ND; Tanguturi SK; Aizer AA; Wen PY; Reardon DA; Lee EQ; Nayak L; Christianson LW; Horvath MC; Dunn IF; Golby AJ; Johnson MD; Claus EB; Chiocca EA; Ligon KL; Alexander BM
    Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):384-9. PubMed ID: 25841623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypofractionated short-course radiotherapy in elderly patients with glioblastoma multiforme: an analysis of the National Cancer Database.
    Mak KS; Agarwal A; Qureshi MM; Truong MT
    Cancer Med; 2017 Jun; 6(6):1192-1200. PubMed ID: 28440040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glioblastoma multiforme (GBM) in the elderly: initial treatment strategy and overall survival.
    Glaser SM; Dohopolski MJ; Balasubramani GK; Flickinger JC; Beriwal S
    J Neurooncol; 2017 Aug; 134(1):107-118. PubMed ID: 28527010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival following CyberKnife radiosurgery and hypofractionated radiotherapy for newly diagnosed glioblastoma multiforme.
    Lipani JD; Jackson PS; Soltys SG; Sato K; Adler JR
    Technol Cancer Res Treat; 2008 Jun; 7(3):249-55. PubMed ID: 18473497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of hypofractionated intensity-modulated irradiation in the treatment of glioblastoma multiforme: preliminary results of a prospective trial.
    Sultanem K; Patrocinio H; Lambert C; Corns R; Leblanc R; Parker W; Shenouda G; Souhami L
    Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):247-52. PubMed ID: 14697445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypofractionated accelerated radiotherapy (HART) with concurrent and adjuvant temozolomide in newly diagnosed glioblastoma: a phase II randomized trial (HART-GBM trial).
    Mallick S; Kunhiparambath H; Gupta S; Benson R; Sharma S; Laviraj MA; Upadhyay AD; Julka PK; Sharma D; Rath GK
    J Neurooncol; 2018 Oct; 140(1):75-82. PubMed ID: 29936695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypofractionated radiotherapy for elderly or younger low-performance status glioblastoma patients: outcome and prognostic factors.
    Chang EL; Yi W; Allen PK; Levin VA; Sawaya RE; Maor MH
    Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):519-28. PubMed ID: 12738329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypofractionated radiation therapy (HFRT) versus conventional fractionated radiation therapy (CRT) for newly diagnosed glioblastoma patients. A propensity score matched analysis.
    Navarria P; Pessina F; Franzese C; Tomatis S; Perrino M; Cozzi L; Simonelli M; Bello L; Clerici E; Riva M; Santoro A; Scorsetti M
    Radiother Oncol; 2018 Apr; 127(1):108-113. PubMed ID: 29291951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiotherapy for elderly patients with glioblastoma: an assessment of hypofractionation and modern treatment techniques.
    Matsui JK; Perlow HK; Facer BD; McCalla A; Marrazzo L; Detti B; Scorsetti M; Clerici E; Scoccianti S; Navarria P; Trifiletti DM; Gondi V; Bovi J; Huang J; Brown PD; Palmer JD
    Chin Clin Oncol; 2022 Oct; 11(5):38. PubMed ID: 36336897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends and Patterns of Utilization of Hypofractionated Postmastectomy Radiotherapy: A National Cancer Database Analysis.
    Venigalla S; Guttmann DM; Jain V; Sharma S; Freedman GM; Shabason JE
    Clin Breast Cancer; 2018 Oct; 18(5):e899-e908. PubMed ID: 29550285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival after hypofractionation in glioblastoma: a systematic review and meta-analysis.
    Trone JC; Vallard A; Sotton S; Ben Mrad M; Jmour O; Magné N; Pommier B; Laporte S; Ollier E
    Radiat Oncol; 2020 Jun; 15(1):145. PubMed ID: 32513205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of hypofractionated radiation therapy in elderly patients with newly diagnosed glioblastoma with poor prognosis.
    Navarria P; Pessina F; Cozzi L; Tomatis S; Reggiori G; Simonelli M; Santoro A; Clerici E; Franzese C; Carta G; Conti Nibali M; Bello L; Scorsetti M
    Tumori; 2019 Feb; 105(1):47-54. PubMed ID: 30131010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypofractionated intensity-modulated radiotherapy for primary glioblastoma multiforme.
    Floyd NS; Woo SY; Teh BS; Prado C; Mai WY; Trask T; Gildenberg PL; Holoye P; Augspurger ME; Carpenter LS; Lu HH; Chiu JK; Grant WH; Butler EB
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):721-6. PubMed ID: 14967426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase 2 trial of hypofractionated high-dose intensity modulated radiation therapy with concurrent and adjuvant temozolomide for newly diagnosed glioblastoma.
    Iuchi T; Hatano K; Kodama T; Sakaida T; Yokoi S; Kawasaki K; Hasegawa Y; Hara R
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):793-800. PubMed ID: 24495592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interim Results of a Phase II Study of Hypofractionated Radiotherapy with Concurrent Temozolomide Followed by Adjuvant Temozolomide in Patients over 70 Years Old with Newly Diagnosed Glioblastoma.
    Yusuf M; Ugiliweneza B; Amsbaugh M; Boakye M; Williams B; Nelson M; Hattab EM; Woo S; Burton E
    Oncology; 2018; 95(1):39-42. PubMed ID: 29694955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypofractionated radiation therapy and temozolomide in patients with glioblastoma and poor prognostic factors. A prospective, single-institution experience.
    Jablonska PA; Diez-Valle R; Pérez-Larraya JG; Moreno-Jiménez M; Idoate MÁ; Arbea L; Tejada S; Garcia de Eulate MR; Ramos L; Arbizu J; Domínguez P; Aristu JJ
    PLoS One; 2019; 14(6):e0217881. PubMed ID: 31170245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guiding Treatment Choices for Elderly Patients with Glioblastoma by a Comprehensive Geriatric Assessment.
    Lütgendorf-Caucig C; Freyschlag C; Masel EK; Marosi C
    Curr Oncol Rep; 2020 Jul; 22(9):93. PubMed ID: 32651730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.